We previously demonstrated in vivo that MSCs decreased Th17 cell differentiation to promote recovery from ALI and inhibition of Th17 cells using IL-17 or IL-22 antibodies also alleviated ALI by inhibiting the recruitment of neutrophils and macrophages [18, 39]. The gene discussed is IL22; the disease is acute respiratory distress syndrome.